Doris M. Ponce

Memorial Sloan Kettering Cancer Center — United States

Medicine · Health Sciences

31h-index5.8kcitations313works1.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hematopoietic Stem Cell Transplantation(193), Acute Myeloid Leukemia Research(64), Acute Lymphoblastic Leukemia research(48), Renal Transplantation Outcomes and Treatments(43), Cytomegalovirus and herpesvirus research(36)

Publications310 total

Effect of Mycophenolate Mofetil Levels on Transplant Outcomes in Patients Treated with Post-Transplant Cyclophosphamide Based GVHD Prophylaxis
Transplantation and Cellular Therapy·2026
Clinical and Disease Characteristics of Initial Participants at Time of Enrollment in THRIVE, a Prospective, Longitudinal, Observational cohort study of Patients at Risk for Chronic Graft-Versus-Host Disease
Transplantation and Cellular Therapy·2026
Pharmacokinetic Modeling Identifies Optimal Fludarabine Exposure for Improved Outcomes Following Allogeneic Transplantation with Post-Transplant Cyclophosphamide
Transplantation and Cellular Therapy·2026
Survival of the Oldest-Old: Allogeneic Transplantation Above 75 Years of Age
Transplantation and Cellular Therapy·2026
A Blood Inflammatory Signature Independently Predicts Treatment Failure after Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia
Transplantation and Cellular Therapy·2026
Implementation of a Novel Patient-Reported Outcome Collection System in THRIVE, a Prospective, Longitudinal, Observational cohort study of Patients at Risk for Chronic Graft-Versus-Host Disease
Transplantation and Cellular Therapy·2026
Low-Volume Diarrhea As an Early Indicator of Lower Gastrointestinal Acute Graft-Versus-Host Disease (Stage 0+): High Response Rates to Topical Steroids
Transplantation and Cellular Therapy·2026
Toward Better Response Assessment of Cutaneous Chronic Graft-Versus-Host Disease: A Report from the National Institutes of Health Consensus Project Task Force
Transplantation and Cellular Therapy·2026Open Access
Model-based antithymocyte globulin dosing in ex vivo CD34+ selected allogeneic haematopoietic cell transplantation: a single-centre, single-arm, phase 2 study
The Lancet Haematology·2025
Allogeneic hematopoietic cell transplantation in acute myeloid leukemia not in complete remission: outcomes and prognostic factors in a contemporary cohort
Blood Cancer Journal·2025Open Access
Clinical and disease characteristics of initial participants at time of enrollment in THRIVE, a prospective, observational cohort study of patients at risk for chronic graft‑versus‑host disease
Blood·2025
Stage 0+ lower gastrointestinal (LGI) acute graft-versus-host disease (aGVHD) is associated with high response to non-systemic treatment, low incidence of moderate to severe chronic graft-versus-host disease (cGVHD) and low non-relapse mortality (NRM)
Blood·2025Open Access
Limitations of the IWG-MRT/ELN response criteria in defining post-transplant remission and clinical success in patients with myelofibrosis: A retrospective study
Blood·2025Open Access
Fludarabine pharmacokinetic model identifies an optimal exposure associated with improved outcomes in allogeneic hematopoietic cell transplantation recipients receiving post-transplant cyclophosphamide
Blood·2025Open Access
Outcomes of Terminal Complement Blockade in Adults with High-Risk Transplant-Associated Thrombotic Microangiopathy: A Comparative Analysis
Transplantation and Cellular Therapy·2025Open Access
Real-world experience of belumosudil and belumosudil/ruxolitinib combination in steroid-refractory chronic graft-versus-host disease
Bone Marrow Transplantation·2025
POS1132 Skin involvement in the Catastrophic Antiphospholipid Syndrome (CAPS): Prevalence, clinical manifestations, histopathological features, correlation with antibody profile and mortality
Annals of the Rheumatic Diseases·2025Open Access
Post-Transplant Pain and Paralysis: Neurologic Amyotrophy as an Atypical Cause of Shoulder Dysfunction Following Hematopoietic Stem Cell Transplant
Cancers·2025· 1 citedOpen Access
Allogeneic hematopoietic cell transplantation for acute leukemia patients not in complete remission.
Journal of Clinical Oncology·2025
Exploratory analyses of immune reconstitution biomarkers from a Ph1b study of an investigational, oral, live biotherapeutic, SER-155, in adult allo-HCT.
Journal of Clinical Oncology·2025· 1 cited
page 1 of 16Next →

Frequent Co-authors

Miguel‐Angel Perales(39), Sergio Giralt(39), Juliet N. Barker(34), Sean M. Devlin(31), James W. Young(23), Ann A. Jakubowski(21), Marcel R.M. van den Brink(20), Esperanza B. Papadopoulos(20), Andromachi Scaradavou(19), Craig S. Sauter(18), Nancy A. Kernan(17), Molly Maloy(16), Parastoo B. Dahi(15), Richard J. O’Reilly(14), Marissa Lubin(14), Hugo Castro‐Malaspina(13), Roni Tamari(13), Jonathan U. Peled(12), Boglarka Gyurkocza(12), Robert R. Jenq(11)